Arvinas Starts ARV-6723 Dosing, Reports $558.9 Million in Liquidity
Image: TokenPost
Arvinas expects initial monotherapy data for ARV-6723 in the second half of 2027, while ARV-393 data are planned for a December hematology meeting.
Read the full story on TokenPostBeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.
